Company Analysis
Sign in

HCW Biologics Inc. (HCWB)

Nasdaq: HCWB · Pharmaceutical Preparations · Miramar, FL · filing with the SEC since 2020
Full chart Alerts Compare
Grade2.3
◀ Past 1.8● Present 2.6▶ Future 2.4
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

10 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to HCW Biologics Inc.’s names, not what it holds today.

Patents granted
10
10 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 4 in 2024 and 3 in 2023
Applications published
26
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology10
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
HCW Biologics, Inc. its own name
US, as the owner printed on each patent
10 granted
15 published
HCW Biologics, Inc. its own name
named as the applicant on its applications, in US
0 granted
11 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 26, 202512,398,189Methods of activating regulatory T cellsBiotechnologyHCW Biologics, Inc.
Jul 2, 202412,024,545Methods of treating aging-related disordersBiotechnologyHCW Biologics, Inc.
Jun 25, 202412,018,071Single-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
May 21, 202411,987,619Single-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
Jan 30, 202411,884,712Multi-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
Aug 29, 202311,738,052Multi-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
Aug 22, 202311,730,762Methods for stimulating proliferation or differentiation of an immune cell with a multi-chain chimeric polypeptideBiotechnologyHCW Biologics, Inc.
Jun 13, 202311,672,826Methods of treating aging-related disordersBiotechnologyHCW Biologics, Inc.
Dec 6, 202211,518,792Multi-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
Aug 2, 202211,401,324Single-chain chimeric polypeptides and uses thereofBiotechnologyHCW Biologics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jan 9, 20252025/0011380METHODS OF TREATING AGING-RELATED DISORDERSPharmaceuticalsHCW Biologics, Inc.
Nov 14, 20242024/0376187SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc.
Apr 25, 20242024/0132561MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc.
Apr 18, 20242024/0124544MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc.
Apr 18, 20242024/0124543MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc.
Dec 14, 20232023/0398151METHODS FOR STIMULATING PROLIFERATION OR DIFFERENTIATION OF AN IMMUNE CELL WITH A MULTI-CHAIN CHIMERIC POLYPEPTIDEBiotechnologyHCW Biologics, Inc.
Nov 30, 20232023/0381238MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc. · patent 12,479,899 granted from it
Nov 23, 20232023/0372444METHODS OF REDUCING NEUROINFLAMMATIONPharmaceuticalsHCW Biologics, Inc.
Nov 23, 20232023/0372399METHODS OF TREATING AGING-RELATED DISORDERSBiotechnologyHCW Biologics, Inc.
Aug 31, 20232023/0272027MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOFBiotechnologyHCW Biologics, Inc. · patent 12,509,494 granted from it
What it applied for, 2024 to 2025: Biotechnology 4 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton HCWB · research, not advice